Fertility

Levine et al.'s 2023 meta-analysis of over 57,000 men confirmed a sperm concentration decline from 101.2 million per millilitre in 1973 to 49.0 million per millilitre by 2018, a fall of 51.6 per cent over forty-five years. The full-period regression slope was minus 1.17 million per millilitre per year. A sub-analysis restricting the data to samples collected after 2000 found the slope had accelerated to minus 1.73 million per millilitre per year, approximately forty-eight per cent faster. There was no statistical evidence of the decline levelling off at either end of the study period.

The acceleration is the more alarming finding. The 1973 to 2000 period was already producing a steep decline; the post-2000 data shows that decline rate increasing rather than stabilising. If the post-2000 trajectory continues linearly, average Western sperm concentration approaches the World Health Organisation's reference threshold of sixteen million per millilitre by the mid-2050s. Levine described the findings as pointing to a "crisis in male reproductive health that has serious implications for human survival."

The 2017 paper by the same lead author, covering Western men specifically (n = 42,935), found a fifty-nine per cent decline in total sperm count between 1973 and 2011. No single cause has been identified. Candidate mechanisms span dietary omega-6 load, phthalate and BPA exposure, seed-oil-derived adipose tissue composition, endocrine disruption and sedentary behaviour, all of which have increased in parallel with the sperm decline since the 1960s.

Levine et al. (2017, Human Reproduction Update) meta-analysed 185 studies (42,935 men) and found a 52.4% decline in sperm concentration and 59.3% decline in total sperm count among Western men from 1973 to 2011. The updated analysis (Levine et al., 2023, Human Reproduction Update) extended through 2018 and found the decline accelerating: post-2000 data showed a steeper annual decline rate of 2.64% per year versus 1.16% in earlier decades. Non-Western countries now show similar trajectories.

This is because spermatogenesis is exquisitely sensitive to endocrine disruptors, heat, oxidative stress and nutrient deficiency. Phthalates (Swan et al., 2015), BPA (Meeker et al., 2010), pesticide residues (Chiu et al., 2015) and electromagnetic radiation (Agarwal et al., 2009) all independently reduce sperm parameters at exposure levels found in the general population. These exposures are additive and often synergistic: the cocktail effect means the sum exceeds the parts.

At the current rate of decline, median sperm count will reach zero by approximately 2045 (extrapolation from Levine 2023 trajectory). That figure is a mathematical consequence of the observed rate. The question is whether the decline will decelerate, plateau or continue. No environmental factor driving the decline has been removed. Most are increasing.

Hayes et al. exposed male African clawed frogs to 2.5 ppb of atrazine from the tadpole stage for three years. Seventy-five percent were chemically castrated and 10% developed functional ovaries capable of producing viable eggs. The EPA drinking water limit for atrazine is 3 ppb. Atrazine induces aromatase, which converts androgens to oestrogens.

Swan et al. found prenatal phthalate exposure in human mothers was inversely correlated with anogenital distance in their male infants, replicating in humans what had previously been documented only in rodents. BPA is detected in over 90% of human urine samples globally. Atrazine has been banned in the EU since 2004 but remains one of the most widely used herbicides in the United States at 36 million kilograms per year.

England and Wales recorded a total fertility rate of 1.41 in 2024, the lowest in history and less than half the 1964 peak of 2.93. The rate dropped below the replacement level of 2.1 in 1973 and has never recovered. That is 52 consecutive years of demographic decline.

The pattern is global. South Korea hit 0.72 in 2023, Japan 1.20, Spain 1.19, Italy 1.20. Israel remains the only OECD nation above replacement at 2.89. Every developed economy now faces the same trajectory at different speeds.

The IARC classified the combined oral contraceptive pill as a Group 1 carcinogen in 1999, reaffirmed in 2007 and again in 2012 under Monograph 100A. This places it in the same evidence category as tobacco smoke, asbestos and processed meat. Sufficient evidence exists for cancer of the breast, cervix and liver.

The Collaborative Group meta-analysis of 54 studies across 25 countries found current pill users had a relative risk of 1.24 for breast cancer. For cervical cancer with five or more years of use, the relative risk reached 1.90. Risk declines after cessation and returns to baseline within approximately ten years. The pill also reduces ovarian and endometrial cancer risk.

Gaskins et al. (2012, Human Reproduction) studied 188 men and found that a "prudent" dietary pattern (fish, fruit, vegetables, whole grains) was associated with 65 per cent higher sperm concentration and 75 per cent higher total motile count compared to a "Western" pattern (processed meat, refined grains, sugar, seed oils). A meta-analysis by Salas-Huetos et al. (2017, Human Reproduction Update) of 28 studies confirmed that healthy dietary patterns consistently improve all semen parameters.

This is because spermatogenesis takes 74 days and is metabolically intensive, requiring robust antioxidant defence (zinc, selenium, vitamin C, vitamin E), adequate omega-3 DHA for membrane fluidity and stable hormone levels. Seed oils provide excess omega-6 that incorporates into sperm membranes, increasing susceptibility to lipid peroxidation. Trans fats are inversely associated with sperm concentration in a dose-dependent manner (Chavarro et al., 2011, Human Reproduction).

A randomised trial by Robbins et al. (2012, Fertility and Sterility) found that men consuming 75g of walnuts per day for 12 weeks had significantly improved sperm vitality, motility and morphology compared to controls. The nutritional intervention worked: no pharmaceutical has demonstrated comparable efficacy for male subfertility. Yet fertility clinics overwhelmingly offer IVF (£5,000 to £7,000 per cycle) before dietary assessment.

One in every 32 UK births is now conceived through IVF, up from one in 77 in 2000. The HFEA recorded 77,500 IVF cycles in 2023 across 141 licensed clinics, with the broader fertility services market reaching £505 million. NHS funding has dropped from 40% of cycles in 2012 to just 27% in 2023.

Success rates vary sharply by age. Live birth rates per fresh embryo transfer are 35% for women under 35 but fall to 5% for women aged 43 to 44. The average true cost per cycle including medication is £6,939. For women aged 40 to 44, 11% of all births now involve IVF.

Five variables tracked from 1960 to 2024 all show sustained directional shifts. The UK total fertility rate fell from 2.68 in 1960 to 1.41 in 2024, a 47% decline, according to ONS primary birth registration data. Western male sperm concentration fell from an estimated 101.2 million/mL in 1973 to 49.0 million/mL in 2018, a 51.6% decline, according to Levine et al.'s 2023 global meta-regression of 57,000 men. The post-2000 slope of sperm decline accelerated from −1.17 to −1.73 million/mL per year. Male testosterone declined at approximately 1.0 to 1.2% per year in population-level studies, with the Travison 2007 MMAS finding a 16% age-matched decline at the same age over just fifteen years.

Two environmental exposure variables moved in the opposite direction over the same period. Dietary linoleic acid intake in the UK roughly doubled from approximately 2% to 6% of total energy between 1960 and 2000 as seed oil consumption expanded, before declining slightly as rapeseed oil displaced higher-linoleic sunflower oil after 2005. Global BPA production rose from negligible quantities in the early 1960s to 6.2 million tonnes in 2020, a twenty-fold increase. BPA is detectable in ninety per cent or more of Western adults and in the cord blood of newborns. Both compounds act on gonadal function: linoleic acid-derived oxidised metabolites damage Leydig and Sertoli cells, while BPA binds oestrogen and androgen receptors antagonistically, suppressing testosterone synthesis and impairing spermatogenesis.

The three biological declines are not fully explained by behavioural or demographic factors. Travison 2007 found the testosterone decline persisted after adjustment for BMI, smoking, medications and health status. Levine 2023 found the sperm decline accelerated post-2000 in studies from all continents simultaneously. The shared timing, directionality and magnitude across three independent markers, in parallel with two rising chemical exposures, constitutes a convergent signal that exceeds what chance or lifestyle changes alone can account for.

The same Danish research group tracked 475,802 women over a mean of 8.3 years, covering 3.9 million person-years of follow-up. Current users of hormonal contraception had a hazard ratio of 1.97 for first suicide attempt and 3.08 for completed suicide. The contraceptive patch carried the highest formulation-specific risk at 3.28 for attempt.

In absolute terms, the authors estimated 1,400 additional first suicide attempts and 12 additional suicides per million person-years attributable to hormonal contraception use. Risk peaked after two months of use. These findings were published in the American Journal of Psychiatry, not a fringe publication.

A prospective cohort of 1,061,997 Danish women aged 15 to 34, followed for a mean of 6.4 years, found that combined oral contraceptive users had a 23% higher risk of first antidepressant use compared with non-users. Adolescents aged 15 to 19 showed an 80% higher risk. The contraceptive patch doubled the risk.

Risk was highest in the first six months of use and declined with age. Progestogen-only pills carried a 34% increase, the vaginal ring 60% and the hormonal IUD 40%. This remains the largest prospective study ever conducted on hormonal contraception and mood.

Women normally prefer the body odour of men with dissimilar MHC genes, a mechanism that promotes immune diversity in offspring. Roberts et al. tested women before and after initiating pill use and found a significant shift toward preferring MHC-similar men. The control group showed no such change.

The pill simulates a pseudo-pregnant hormonal state in which olfactory preferences shift toward genetically similar individuals, likely reflecting an ancestral pull toward kin. MHC-similar couples face higher rates of recurrent miscarriage and longer intervals between births. When women stop the pill to conceive, established partner attraction may diminish.

Kidd et al. added 5 to 6 ng/L of ethinylestradiol to a Canadian lake and tracked fathead minnows for seven years. Males developed eggs in their testes, breeding collapsed and the population neared extinction. Recovery took four years after dosing stopped.

Jobling et al. documented intersex male roach at 86% of 51 UK river sites surveyed, directly correlated with the proportion of sewage effluent in the water. EE2 concentrations of 0.5 to 7 ng/L are routinely detected in European surface waters. These synthetic oestrogens survive standard sewage treatment and enter the water cycle from the urine of contraceptive pill users.